Cytovale | Latest News & Updates - Nov 13, 2024 Release
Cytovale won the 'Biggest Healthcare Savings Story' award at the DigiHlthHubFdn Awards 2024 for reducing healthcare costs...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Cytovale
🌎 cytovale.comCytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test analyzes white blood cells to stratify a patient’s risk of sepsis in under 10 minutes, addressing the urgent need for early detection of this lethal condition.
Cytovale - Latest News and Updates
- Cytovale won the 'Biggest Healthcare Savings Story' award at the DigiHlthHubFdn Awards 2024 for reducing healthcare costs.
- Jessica Taylor has joined Cytovale as a Senior Clinical Consultant in the United States, previously working as an Emergency Nurse at Endeavor Health.
- Cytovale's IntelliSep test showed a 98% negative predictive value for sepsis in a study of over 1,000 adult emergency department patients.
- Cytovale is hiring for positions to enhance sepsis detection and patient care.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.